VistaGen Therapeutics, Inc. company info

CIK 1411685
IRS Number 205093315
State of incorporation NV
Business address 343 ALLERTON AVENUE
None
SOUTH SAN FRANCISCO
CA
94080
Mail address 343 ALLERTON AVENUE
None
SOUTH SAN FRANCISCO
CA
94080

Short summary

VistaGen Therapeutics, Inc. is a California company, with head office located at 343 Allerton Avenue South San Francisco, California 94080. In 2019 the company owned a total of 5.33 million USD worth of assets, including 1.38 million USD worth of current assets. 2018 was the year when the company amassed the most assets.

VistaGen Therapeutics, Inc. Income Statement

Name [in Millions USD]19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019Trends
Research and development 3.685.393.432.482.433.935.207.7617.10
Operating Expenses 8.6410.396.995.036.7817.8511.5014.2024.56
Operating Income (Loss) -6.56-9.04-6.79-5.03-6.78-17.85-10.25-14.20-24.56
Interest expense 3.121.89-0.921.504.550.770.000.010.01
Other Nonoperating Income (Expense) -0.14-0.000
Income Tax Expense (Benefit) 0.000.000.000.000.000.000.000.000.00
Net income -0.70-1.81-2.11-0.50-8.76-1.08-1.77-2.00-5.45-4.70-4.12-9.48-12.21-12.89-2.97-13.89-47.22-10.26-14.35-24.59

VistaGen Therapeutics, Inc. Balance Sheet

Name [in Millions USD]19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019Trends
Cash and cash equivalents 0.100.940.030.090.400.128.501.637.238.301.06
Property, Plant and Equipment, Gross 0.600.730.780.780.801.051.221.251.25
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -0.53-0.55-0.61-0.670.710.760.860.961.01
Other Assets, Noncurrent 0.030.030.030.050.050.050.050.050.050.05
Total assets 1.680.650.430.761.748.762.448.2612.955.33
Current assets 1.580.540.220.551.598.632.137.858.781.38
Accounts payable 0.942.561.761.901.550.930.630.630.931.61
Total current liabilities 5.544.392.936.203.281.601.001.873.312.94
Long-term Debt, Excluding Current Maturities 1.0400
Long-term Debt 2.062.220.06
Total liabilities 8.756.9312.3816.164.612.603.045.0311.3211.43
Common Stock, Value, Issued 0.020.020.020.030.000.010.010.020.040.04
Retained Earnings (Accumulated Deficit) -44.98-56.61-67.48-75.19-114.05-133.71-144.26-160.76-187.34-198.64

VistaGen Therapeutics, Inc. Cash Flow

Name [in Millions USD]19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019Trends
Net income -0.70-1.81-2.11-0.50-8.76-1.08-1.77-2.00-5.45-4.70-4.12-9.48-12.21-12.89-2.97-13.89-47.22-10.26-14.35-24.59
Depreciation and amortization 0.050.050.030.050.060.080.09
Depreciation and amortization 0.060.050.050.080.09
Accounts receivable 0.21-0.060.11
Deferred revenue -0.06-0.07-0.01
Net Cash Provided by (Used in) Operating Activities -0.84-3.57-3.46-2.13-2.77-9.06-14.53
Payments to Acquire Property, Plant, and Equipment 0.030.240.000.17
Net Cash Provided by (Used in) Investing Activities -0.06-0.03-0.140.01-0.03-0.24-0.00-0.17
Proceeds from Issuance of Common Stock 2.681.191.083.130.289.9016.7217.04
Net Cash Provided by (Used in) Financing Activities 0.843.544.161.502.8416.5217.42
Cash and Cash Equivalents, Period Increase (Decrease) -0.06-0.060.56-0.640.070.362.497.462.72